Fig 1.
MAS, Modified Ashworth Scale; FAS, full analysis set; PPS, per-protocol set.
Table 1.
Baseline Characteristics of Study Participants from the Full Analysis Set.
Table 2.
Changes in the Wrist Flexor Spasticity Measured by the Modified Ashworth Scale at Week 4.
Fig 2.
Changes of Modified Ashworth Scale (MAS) at each muscle group.
Fig 3.
Response rates for each muscle group.
Table 3.
Changes from Baseline according to the Disability Assessment Scale.
Table 4.
Changes from Baseline according to the Carer Burden Scale.
Table 5.
Global Assessment of the Treatment Benefit by the Physician and the Patient/Caregiver at 12 Weeks after Injection.
Table 6.
Injected Doses of Botulinum Toxin Type A in a Safety Set.